| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.
|
Am J Gastroenterol
|
2013
|
7.81
|
|
2
|
An evidence-based position statement on the management of irritable bowel syndrome.
|
Am J Gastroenterol
|
2009
|
3.99
|
|
3
|
Treating Clostridium difficile infection with fecal microbiota transplantation.
|
Clin Gastroenterol Hepatol
|
2011
|
3.81
|
|
4
|
Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.
|
J Clin Gastroenterol
|
2010
|
1.88
|
|
5
|
Mesenteric venous thrombosis.
|
Vasc Med
|
2010
|
1.71
|
|
6
|
Fecal microbiota transplantation: past, present and future.
|
Curr Opin Gastroenterol
|
2013
|
1.59
|
|
7
|
Ismar Boas: father of gastroenterology and founder of the oldest surviving publication in digestive diseases.
|
Am J Gastroenterol
|
2011
|
1.57
|
|
8
|
Clostridium difficile infection and inflammatory bowel disease.
|
J Clin Gastroenterol
|
2013
|
1.57
|
|
9
|
Ischemic colitis has a worse prognosis when isolated to the right side of the colon.
|
Am J Gastroenterol
|
2007
|
1.45
|
|
10
|
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.
|
Am J Gastroenterol
|
2009
|
1.39
|
|
11
|
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study).
|
Scand J Gastroenterol
|
2010
|
1.33
|
|
12
|
Recommendations for probiotic use-2011 update.
|
J Clin Gastroenterol
|
2011
|
1.19
|
|
13
|
Colon ischemia: recent insights and advances.
|
Curr Gastroenterol Rep
|
2010
|
1.11
|
|
14
|
The FDA's decision-making process: isn't it time to temper the principle of protective paternalism?
|
Am J Gastroenterol
|
2008
|
1.10
|
|
15
|
Editorial commentary: fecal microbiota transplantation: patient and physician attitudes.
|
Clin Infect Dis
|
2012
|
1.08
|
|
16
|
Intestinal ischemia.
|
Gastroenterol Clin North Am
|
2003
|
1.07
|
|
17
|
The intestinal microbiota and obesity.
|
J Clin Gastroenterol
|
2012
|
1.06
|
|
18
|
Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease.
|
Am J Gastroenterol
|
2010
|
1.06
|
|
19
|
Diverticular disease of the colon does not increase risk of repeat C. difficile infection.
|
J Clin Gastroenterol
|
2013
|
1.04
|
|
20
|
Endoscopic fecal microbiota transplantation: "first-line" treatment for severe clostridium difficile infection?
|
J Clin Gastroenterol
|
2011
|
0.99
|
|
21
|
Report of the multisociety task force on GI training.
|
Gastroenterology
|
2009
|
0.96
|
|
22
|
Postoperative Clostridium difficile-associated diarrhea.
|
Surgery
|
2010
|
0.95
|
|
23
|
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
|
J Clin Gastroenterol
|
2016
|
0.93
|
|
24
|
Report of the Multisociety Task Force on GI training.
|
Gastrointest Endosc
|
2009
|
0.93
|
|
25
|
The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
|
J Clin Gastroenterol
|
2016
|
0.92
|
|
26
|
Therapeutic faecal microbiota transplantation: current status and future developments.
|
Curr Opin Gastroenterol
|
2014
|
0.92
|
|
27
|
Pharmacologically mediated colon ischemia.
|
Am J Gastroenterol
|
2007
|
0.90
|
|
28
|
Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion.
|
J Clin Gastroenterol
|
2015
|
0.89
|
|
29
|
Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection.
|
Expert Rev Anti Infect Ther
|
2013
|
0.87
|
|
30
|
The impact of ethnicity and obesity on the course of colonic diverticulitis.
|
J Clin Gastroenterol
|
2013
|
0.86
|
|
31
|
On the role of ischemia in the pathogenesis of IBD: a review.
|
Inflamm Bowel Dis
|
2010
|
0.85
|
|
32
|
Report of the Multisociety Task Force on GI training.
|
Hepatology
|
2009
|
0.80
|
|
33
|
Pharmacologic management of mesenteric occlusive disease.
|
Cardiol Rev
|
2008
|
0.79
|
|
34
|
FMT: first step in a long journey.
|
Am J Gastroenterol
|
2013
|
0.78
|
|
35
|
Flexible sigmoidoscopy: the patients' perception.
|
Gastrointest Endosc
|
2002
|
0.78
|
|
36
|
Deformation of the anus: an alternative to rectal air suctioning for patient comfort after colonoscopy.
|
Gastrointest Endosc
|
2004
|
0.77
|
|
37
|
Drug therapies for mesenteric vascular disease.
|
Heart Dis
|
2002
|
0.76
|
|
38
|
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice.
|
Gastroenterology
|
2009
|
0.75
|
|
39
|
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technology.
|
Gastrointest Endosc
|
2012
|
0.75
|
|
40
|
The lament of the chief complaint: not one, not always, but a good conversational start.
|
Am J Gastroenterol
|
2007
|
0.75
|
|
41
|
Chronic mesenteric ischemia and visible light spectroscopy: can a dark path be illuminated?
|
Gastrointest Endosc
|
2006
|
0.75
|
|
42
|
Ischemic colitis complicating aortic dissection.
|
Gastrointest Endosc
|
2002
|
0.75
|
|
43
|
Pseudolipomatosis polyposis.
|
Gastrointest Endosc
|
2006
|
0.75
|
|
44
|
Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease.
|
J Clin Gastroenterol
|
2017
|
0.75
|
|
45
|
Acid-related disorders from pediatrics to geriatrics: reducing risks and optimizing outcomes.
|
Am J Med
|
2004
|
0.75
|